Last Year’s Consent Form, This Year’s GLP-1 Warning.
Credit: Caitlin A. Koppenhaver, Esq. On November 9, 2026, FDA announced a new labeling requirement for approved GLP-1 medications, including semaglutide and tirzepatide. The warning concerns a rare eye condition that can
